Abacus Planning Group, Inc.
Source: SEC Form 13F · as of Mar 2026Abacus Planning Group, Inc. holds 18 biotech & pharma companies tracked by BioSniper, totaling $13.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$13.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 10,016 | $2.4M |
| LLYELI LILLY & Co | 2,469 | $2.3M |
| MRKMerck & Co., Inc. | 13,266 | $1.6M |
| AMGNAMGEN INC | 3,730 | $1.3M |
| CAHCardinal Health Inc. | 4,344 | $918K |
| GMOptec International, Inc. | 9,981 | $744K |
| PFEPFIZER INC | 25,480 | $715K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,971 | $533K |
| VTRSViatris Inc | 39,261 | $530K |
| ABBVAbbVie Inc. | 2,373 | $516K |
| PMPhilip Morris International Inc | 2,385 | $394K |
| BMYBRISTOL MYERS SQUIBB CO | 5,508 | $334K |
| BIIBBIOGEN INC. | 1,760 | $323K |
| BAXBaxter International Inc. | 14,911 | $251K |
| MCKMcKesson Corporation | 279 | $241K |
| SGMTSagimet Biosciences Inc. | 18,064 | $94K |
| PRMEPrime Medicine, Inc. | 25,188 | $88K |
| FBIOFortress Biotech Inc. | 14,534 | $41K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.